300869 康泰医学
交易中 06-03 14:02:09
资讯
新帖
简况
股市必读：康泰医学（300869）今年截至6月2日累计跌幅已超25%
证券之星 · 03:32
股市必读：康泰医学（300869）今年截至6月2日累计跌幅已超25%
康泰医学（300869）披露全资子公司牙科氧化锆陶瓷获欧盟MDR认证，5月25日股价下跌1.08%
证券之星 · 05-25
康泰医学（300869）披露全资子公司牙科氧化锆陶瓷获欧盟MDR认证，5月25日股价下跌1.08%
康泰医学(300869.SZ)子公司产品获得欧盟MDR认证
智通财经 · 05-25
康泰医学(300869.SZ)子公司产品获得欧盟MDR认证
康泰医学(300869.SZ)：“超声骨密度仪”获得医疗器械注册证
智通财经 · 05-20
康泰医学(300869.SZ)：“超声骨密度仪”获得医疗器械注册证
康泰医学（300869）披露2025年度股东会决议公告，5月20日股价下跌2.1%
证券之星 · 05-20
康泰医学（300869）披露2025年度股东会决议公告，5月20日股价下跌2.1%
康泰医学新注册《ECG系列心电图机软件V1.0》等2个项目的软件著作权
证券之星 · 05-20
康泰医学新注册《ECG系列心电图机软件V1.0》等2个项目的软件著作权
康泰医学近两年一期亏损 A股共募11亿IPO申万宏源保荐
中金财经 · 05-18
康泰医学近两年一期亏损 A股共募11亿IPO申万宏源保荐
股市必读：康泰医学（300869）今年截至5月15日累计跌幅已超20%
证券之星 · 05-18
股市必读：康泰医学（300869）今年截至5月15日累计跌幅已超20%
股市必读：康泰医学（300869）5月8日披露最新机构调研信息
证券之星 · 05-11
股市必读：康泰医学（300869）5月8日披露最新机构调研信息
股市必读：康泰医学年报 - 第四季度单季净利润同比增长61.48%
证券之星 · 04-29
股市必读：康泰医学年报 - 第四季度单季净利润同比增长61.48%
图解康泰医学年报：第四季度单季净利润同比增长61.48%
证券之星 · 04-28
图解康泰医学年报：第四季度单季净利润同比增长61.48%
康泰医学(300869)3月31日股东户数3.28万户，较上期减少1.41%
证券之星 · 04-27
康泰医学(300869)3月31日股东户数3.28万户，较上期减少1.41%
康泰医学：迪拜子公司目前正在筹备阶段
证券之星 · 04-15
康泰医学：迪拜子公司目前正在筹备阶段
康泰医学：已形成院线类、家用类和其他类三大产品体系
证券之星 · 04-15
康泰医学：已形成院线类、家用类和其他类三大产品体系
康泰医学：各项整改工作正在有序推进中
证券之星 · 04-10
康泰医学：各项整改工作正在有序推进中
康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权
证券之星 · 04-04
康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权
康泰医学（300869）披露持股5%以上股东权益变动提示性公告，4月3日股价下跌3.03%
证券之星 · 04-03
康泰医学（300869）披露持股5%以上股东权益变动提示性公告，4月3日股价下跌3.03%
康泰医学（300869）披露股东询价转让定价情况提示性公告，3月26日股价下跌1.72%
证券之星 · 03-26
康泰医学（300869）披露股东询价转让定价情况提示性公告，3月26日股价下跌1.72%
康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份
智通财经 · 03-25
康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份
康泰医学（300869）披露公司产品获得CE证书公告，3月2日股价下跌3.04%
证券之星 · 03-02
康泰医学（300869）披露公司产品获得CE证书公告，3月2日股价下跌3.04%
加载更多
公司概况
公司名称：
康泰医学系统(秦皇岛)股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-08-24
主营业务：
康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是家用类产品、院线类产品、其他类产品。
发行价格：
10.16
{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":11.44,"timestamp":1780466529000,"preClose":11.51,"halted":0,"volume":2398900,"delay":0,"changeRate":-0.0061,"floatShares":264000000,"shares":401999999,"eps":-0.1223,"marketStatus":"交易中","change":-0.07,"latestTime":"06-03 14:02:09","open":11.67,"high":11.73,"low":11.39,"amount":27690700,"amplitude":0.0295,"askPrice":11.45,"askSize":50,"bidPrice":11.44,"bidSize":117,"shortable":0,"etf":0,"ttmEps":-0.1223,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780470000000},"marketStatusCode":2,"adr":0,"adjPreClose":11.51,"symbolType":"stock","openAndCloseTimeList":[[1780450200000,1780457400000],[1780462800000,1780470000000]],"highLimit":12.66,"lowLimit":10.36,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401803327,"isCdr":false,"pbRate":2.73,"roa":"--","roe":"--","epsLYR":-0.06,"committee":0.573581,"marketValue":4597000000,"turnoverRate":0.0091,"status":1,"floatMarketCap":3022000000},"requestUrl":"/m/hq/s/300869/","defaultTab":"news","newsList":[{"id":"2640928010","title":"股市必读：康泰医学（300869）今年截至6月2日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640928010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640928010?lang=zh_cn&edition=full","pubTime":"2026-06-03 03:32","pubTimestamp":1780428732,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，康泰医学报收于11.51元，下跌1.62%，换手率0.86%，成交量2.26万手，成交额2613.79万元。来自公司公告汇总：全资子公司长沙康泰医芯获第二类医疗器械经营备案凭证，备案编号为湘长市场监械经营备20261290号，涵盖注输护理、口腔科及临床检验器械的批发零售。交易信息汇总股价提醒6月2日康泰医学收盘报11.51元，跌1.62%，当日成交2613.79万元。该股已连续2日下跌，当年累计跌幅25.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300005980.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638556600","title":"康泰医学（300869）披露全资子公司牙科氧化锆陶瓷获欧盟MDR认证，5月25日股价下跌1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638556600","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638556600?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:57","pubTimestamp":1779721033,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，康泰医学报收于11.94元，较前一交易日下跌1.08%，最新总市值为47.98亿元。该股当日开盘12.07元，最高12.22元，最低11.8元，成交额达3072.01万元，换手率为0.97%。发证机构为SGS Belgium NV NB1639，证书签批时间为2026年5月19日，有效期至2031年5月19日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500034368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FESXmain","FSXEmain","300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638391925","title":"康泰医学(300869.SZ)子公司产品获得欧盟MDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2638391925","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638391925?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:16","pubTimestamp":1779700616,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 康泰医学(300869.SZ)发布公告，公司全资子公司长沙康泰医芯生物科技有限责任公司(以下简称“长沙医芯”)于近日取得欧盟医疗器械法规(Medical Device Regulation (EU) 2017/745，简称“MDR”)认证证书。认证产品：牙科氧化锆陶瓷(型号：HT-Plus、ST、ST-C、ST-ML、SHT、SHT-C、 SHT-ML、UT、UT-C、UT-ML、3D Pro-ML)。此次获得欧盟MDR认证，表明上述产品符合欧盟最新医疗器械法规要求，具备欧盟市场的最新准入条件，可以持续在相关海外市场合法销售，对公司产品在相应市场的推广和销售起到推动作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251","FSXEmain","FESXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636499088","title":"康泰医学(300869.SZ)：“超声骨密度仪”获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2636499088","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636499088?lang=zh_cn&edition=full","pubTime":"2026-05-20 19:06","pubTimestamp":1779275199,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康泰医学(300869.SZ)发布公告，公司于近日取得了由河北省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，该产品为：“超声骨密度仪”。以上产品医疗器械注册证的首次取得，有利于丰富公司产品线，进一步提高公司的核心竞争力，对公司发展具","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","159883","BK1100","BK0251","BK1574","09996","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636458408","title":"康泰医学（300869）披露2025年度股东会决议公告，5月20日股价下跌2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636458408","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636458408?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:17","pubTimestamp":1779272231,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，康泰医学报收于12.11元，较前一交易日下跌2.1%，最新总市值为48.66亿元。该股当日开盘12.37元，最高12.37元，最低12.02元，成交额达3239.15万元，换手率为1.01%。近日，康泰医学系统（秦皇岛）股份有限公司披露《2025年度股东会决议公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636086521","title":"康泰医学新注册《ECG系列心电图机软件V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2636086521","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636086521?lang=zh_cn&edition=full","pubTime":"2026-05-20 01:56","pubTimestamp":1779213373,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康泰医学新注册了2个项目的软件著作权，包括《ECG系列心电图机软件V1.0》、《E系列心电图机软件V1.0》等。今年以来康泰医学新注册软件著作权7个，较去年同期减少了93.86%。通过天眼查大数据分析，康泰医学系统（秦皇岛）股份有限公司共对外投资了7家企业，参与招投标项目473次；财产线索方面有商标信息85条，专利信息666条，著作权信息431条；此外企业还拥有行政许可293个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000001530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636010678","title":"康泰医学近两年一期亏损 A股共募11亿IPO申万宏源保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2636010678","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636010678?lang=zh_cn&edition=full","pubTime":"2026-05-18 09:19","pubTimestamp":1779067159,"startTime":"0","endTime":"0","summary":"中国经济网北京5月18日讯 康泰医学 近日发布的2025年年度报告显示，2025年，公司实现营业收入4.68亿元，同比下降2.46%；归属于上市公司股东的净利润-2442.39万元，上年同期为-7790.26万元；归属于上市公司股东的扣除非经常性损益的净利润-4734.23万元，上年同期为-9507.93万元；经营活动产生的现金流量净额为2228.74万元，同比下降64.25%。 经计算，康泰医学上市以来两次募资共11.17亿元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/18/20260518935901.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/18/20260518935901.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260518/32231917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","399300","159982","BK0028","BK0251","IPOS","000166","BK0012","300869","BK0188","BK1564","06806","BK1147","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636810016","title":"股市必读：康泰医学（300869）今年截至5月15日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636810016","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636810016?lang=zh_cn&edition=full","pubTime":"2026-05-18 03:34","pubTimestamp":1779046453,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，康泰医学报收于12.34元，下跌2.37%，换手率1.48%，成交量3.91万手，成交额4875.04万元。当日关注点来自交易信息汇总：康泰医学股价连续5日下跌，2026年累计跌幅达20.24%。来自交易信息汇总：5月15日主力资金净流出703.06万元，散户资金净流入604.7万元。交易信息汇总股价提醒5月15日康泰医学收盘报12.34元，跌2.37%，当日成交390.83万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634429202","title":"股市必读：康泰医学（300869）5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634429202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634429202?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:27","pubTimestamp":1778444830,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，康泰医学报收于13.06元，上涨2.11%，换手率2.43%，成交量6.41万手，成交额8408.14万元。来自机构调研要点：公司对美国FDA警告信整改工作正有序推进，与FDA保持密切沟通，争取早日关闭警告信。未来如有业务布局调整，将按规定履行信息披露义务。股东及高管减持系个人资金需求所致，公司已依规披露相关信息，将继续坚守主业，提升公司价值，回报投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100002030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631537465","title":"股市必读：康泰医学年报 - 第四季度单季净利润同比增长61.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631537465","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631537465?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:11","pubTimestamp":1777417895,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，康泰医学报收于12.6元，下跌3.3%，换手率1.98%，成交量5.24万手，成交额6678.19万元。业绩披露要点康泰医学2025年年报显示，当年度公司主营收入4.68亿元，同比下降2.46%；归母净利润-2442.39万元，同比上升68.65%；扣非净利润-4734.23万元，同比上升50.21%；其中2025年第四季度，公司单季度主营收入1.24亿元，同比下降15.01%；单季度归母净利润-3382.37万元，同比上升61.48%；单季度扣非净利润-4394.51万元，同比上升50.41%；负债率37.46%，投资收益1672.91万元，财务费用405.68万元，毛利率48.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900019010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630804319","title":"图解康泰医学年报：第四季度单季净利润同比增长61.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630804319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630804319?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:09","pubTimestamp":1777309767,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学2025年年报显示，当年度公司主营收入4.68亿元，同比下降2.46%；归母净利润-2442.39万元，同比上升68.65%；扣非净利润-4734.23万元，同比上升50.21%；其中2025年第四季度，公司单季度主营收入1.24亿元，同比下降15.01%；单季度归母净利润-3382.37万元，同比上升61.48%；单季度扣非净利润-4394.51万元，同比上升50.41%；负债率37.46%，投资收益1672.91万元，财务费用405.68万元，毛利率48.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800003192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630799361","title":"康泰医学(300869)3月31日股东户数3.28万户，较上期减少1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630799361","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630799361?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:32","pubTimestamp":1777282339,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康泰医学披露，截至2026年3月31日公司股东户数为3.28万户，较12月31日减少469.0户，减幅为1.41%。在医疗器械行业个股中，康泰医学股东户数高于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年12月31日至2026年3月31日，康泰医学区间跌幅为11.53%，在此期间股东户数减少469.0户，减幅为1.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700032148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472509","title":"康泰医学：迪拜子公司目前正在筹备阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472509?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:33","pubTimestamp":1776223987,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学(300869)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的中东分公司，有无受到战争影响？后期战后医疗重建是否会受益？康泰医学回复：尊敬的投资者您好，公司新设立的迪拜子公司目前正在筹备阶段，区域局势变化对中东地区物流运输等方面有一定影响。公司将密切关注国际局势及市场环境变化，稳步推进海外业务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472577","title":"康泰医学：已形成院线类、家用类和其他类三大产品体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472577?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:33","pubTimestamp":1776223986,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学(300869)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的主力产品有哪些？是否具备业务护城河能力？康泰医学回复：尊敬的投资者您好，公司已经形成院线类、家用类和其他类三大产品体系，涵盖血氧类、心电类、超声类、监护类、血压类、分析测试类等多类产品。公司深耕行业多年，在研发创新、全产业链、营销网络等方面逐渐形成了自身的综合优势，为公司稳健发展提供了有力支撑。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626154508","title":"康泰医学：各项整改工作正在有序推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2626154508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626154508?lang=zh_cn&edition=full","pubTime":"2026-04-10 09:00","pubTimestamp":1775782858,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学(300869)04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘请问什么时候才能解除FDA警告信？康泰医学回复：尊敬的投资者您好！公司收到FDA警告信后，已在规定时间内向FDA提交了正式回复及整改计划，各项整改工作正在有序推进中，公司与FDA始终保持着密切沟通，争取尽快关闭警告信。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000007702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624669977","title":"康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624669977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624669977?lang=zh_cn&edition=full","pubTime":"2026-04-04 02:05","pubTimestamp":1775239517,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康泰医学新注册了《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权。今年以来康泰医学新注册软件著作权5个，较去年同期减少了95.61%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了4648.11万元，同比减17.08%。通过天眼查大数据分析，康泰医学系统（秦皇岛）股份有限公司共对外投资了7家企业，参与招投标项目472次；财产线索方面有商标信息85条，专利信息663条，著作权信息430条；此外企业还拥有行政许可275个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040400000562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624465486","title":"康泰医学（300869）披露持股5%以上股东权益变动提示性公告，4月3日股价下跌3.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624465486","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624465486?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:34","pubTimestamp":1775212455,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，康泰医学报收于13.1元，较前一交易日下跌3.03%，最新总市值为52.64亿元。该股当日开盘13.45元，最高13.58元，最低13.07元，成交额达4212.95万元，换手率为1.21%。近日，康泰医学披露《股东询价转让结果报告书暨持股5%以上股东持有权益比例降至5%以下的提示性公告》。公告显示，公司持股5%以上股东王桂丽通过集中竞价、大宗交易及询价转让方式减持公司股份，合计持股比例由10.00%下降至4.9999%，持股比例降至5%以下。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622691869","title":"康泰医学（300869）披露股东询价转让定价情况提示性公告，3月26日股价下跌1.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622691869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622691869?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:35","pubTimestamp":1774535718,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，康泰医学报收于13.11元，较前一交易日下跌1.72%，最新总市值为52.68亿元。康泰医学系统（秦皇岛）股份有限公司于2026年3月26日发布《股东询价转让定价情况提示性公告》。本次拟转让股份已获全额认购，初步确定受让方为15家机构投资者，受让股份总数为15,037,100股。本次转让不通过二级市场进行，受让方6个月内不得转让所受让股份。本次转让不涉及公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600044705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622026022","title":"康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2622026022","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622026022?lang=zh_cn&edition=full","pubTime":"2026-03-25 17:01","pubTimestamp":1774429292,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康泰医学(300869.SZ)发布股东询价转让计划书，拟参与公司首发前股东询价转让的股东为王桂丽，出让方拟转让股份的总数为1503.71万股，占公司当前总股本的比例为3.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616415356","title":"康泰医学（300869）披露公司产品获得CE证书公告，3月2日股价下跌3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616415356","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616415356?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:15","pubTimestamp":1772464518,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，康泰医学报收于14.66元，较前一交易日下跌3.04%，最新总市值为58.9亿元。该股当日开盘14.9元，最高14.96元，最低14.66元，成交额达5810.6万元，换手率为1.55%。康泰医学系统（秦皇岛）股份有限公司于近日取得由TV SD Product Service GmbH签发的CE证书，产品名称为Insect bite helper，注册分类为IIa类。该产品获得CE证书表明其符合欧盟相关要求，已具备进入欧盟市场的准入条件，对公司未来经营将产生积极影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780466532413,"stockEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.1084},{"period":"3month","weight":-0.1825},{"period":"6month","weight":-0.2729},{"period":"1year","weight":-0.1951},{"period":"ytd","weight":-0.2327}],"compareEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":-0.009},{"period":"3month","weight":-0.0018},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2174},{"period":"ytd","weight":0.0268}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"32816人(较上一季度减少1.41%)","perCapita":"8049股","listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","registeredCapital":"40180万元","survey":" 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是家用类产品、院线类产品、其他类产品。","listedPrice":10.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}